Developing Infrastructure: Managing Patients With Cancer Undergoing CAR T-Cell Therapy


Area of Science:

• Oncology Nursing
• Cellular Therapy
• Immunotherapy

Background:

• Chimeric antigen receptor (CAR) T-cell therapy presents novel challenges and opportunities for nursing practice.
• Clinical nurses require specialized education to manage new treatment modalities, recognize CAR T-cell therapy toxicities, and support patients.

Purpose of the Study:

• To outline nursing leadership strategies and interventions for standardizing care and ensuring patient safety during CAR T-cell therapy.
• To address the educational needs of nurses in managing CAR T-cell therapy.

Main Methods:

• Development of evidence-based standards of care through interprofessional collaboration and utilization of evolving clinical experience.
• Identification of common toxicities associated with CAR T-cell therapy and establishment of best practices for their management.
• Implementation of electronic documentation forms to create a robust research infrastructure for patient care.

Main Results:

• Enhanced ability to safely manage patients undergoing CAR T-cell treatments.
• Establishment of a new infrastructure that supports clinicians and scientists in improving patient outcomes.
• Demonstration of the critical role of nursing leadership in advancing the care of patients with challenging diseases.

Conclusions:

• Strong nursing leadership is essential for the successful implementation and advancement of CAR T-cell therapy.
• Standardized care protocols and effective toxicity management improve patient safety and outcomes.
• The development of specialized infrastructure facilitates research and transforms the prognosis for patients with severe diseases.